News & Events

13

Jul2020

A WEEK FULL OF NEWS AND HAPPENINGS AT PMPRB

/ News, PMPRB, Upcoming Events, What's New
ALERT! PMPRB WEBINAR RESCHEDULED Given all the new information this week, as well as the consultation extension, PDCI is postponing its PMPRB webinar.  Our second free webinar for industry will now be held on July 22, 2020 between 10:30 am – 12:00 ... Read More

07

Jul2020

NEW PDCI INFOGRAPHIC: Best Practices for CADTH Request for Reconsideration

/ CADTH, News, PDCI
PDCI Market Access Inc. is pleased to share its best practices infographic focused on Requesting Reconsideration under the Canadian Agency for Drugs and Technologies in Health (CADTH) Procedures for the Common Drug Review (CDR). While optional and only appropriate in select circumstances, manufacturers should not overlook this potential opportunity ... Read More

02

Jul2020

Request for Reconsideration

/ CADTH, What's New
Request-for-Reconsideration-To-CADTHDownload

30

Jun2020

PMPRB: Federal Court Quashes Reporting of Third-Party Discounts & Rebates, Upholds other provisions of the Amended Patented Medicines Regulations

/ News, PMPRB
Yesterday, the Federal Court of Canada released its decision in the judicial review challenging the validity of the Regulations Amending the Patented Medicines Regulations that were published in Canada Gazette Part II on August 21, 2019. The judgement and reasons in Innovative ... Read More

30

Jun2020

CADTH Releases Pharmaceutical Reviews Update – Issue 16

/ CADTH, News, What's New
CADTH’s Pharmaceutical Reviews Updates are used to communicate new Common Drug Review (CDR) and pan-Canadian Oncology Drug Review (pCODR) drug review process updates to the public. PDCI has outlined below the key highlights from the most recent update. For more information, please consult the CADTH ... Read More

20

Jun2020

New Draft PMPRB Guidelines: A High Level Summary

/ News, PDCI, PMPRB, What's New
As PDCI announced earlier today, the PMPRB has issued the second draft of the PMPRB Guidelines to support the implementation of Patented Medicines Regulations (Regulations) changes coming unto force on January 1, 2021.  This draft is now available for a 30-day Notice and Comment Period.  Written feedback ... Read More

19

Jun2020

Now Released: PMPRB New Draft Guidelines

/ News, PMPRB, Upcoming Events, What's New
The Patented Medicine Prices Review Board (PMPRB) has just released its second set of Draft Guidelines under the recently amended Patented Medicines Regulations (“Regulations”).  This launches a 30-day consultation period for stakeholders to provide written comments on the new Draft Guidelines.  Stay ... Read More

10

Jun2020

Amendment to the Patented Medicines Regulations Published in Canada Gazette II

/ News, PMPRB, What's New
As expected, amendments to the Patented Medicines Regulations (“Regulations”) were published in Canada Gazette II this morning.  The amendments officially change the coming into force date of the new amending Regulation to January 1, 2021.  These Regulations were originally published in Canada Gazette II on August 21, 2020 with an ... Read More

01

Jun2020

PMPRB Guidelines and Regulations Update

/ News, PDCI, PMPRB, What's New
PMPRB Guidelines and Regulations Update As first disclosed by PDCI last week, the PMPRB Board Chair officially confirmed that the amended Patented Medicines Regulations (“Regulations”) will now come into force on January 1, 2021.  These Regulations were published in Canada Gazette II in August 2019 with ... Read More

29

May2020

Delay of Implementation of PMPRB Amended Regulations to January 1, 2021

/ News, PMPRB, What's New
PDCI Market Access understands from multiple sources that Health Canada is reaching out to stakeholder groups today to confirm the delay of the implementation of the PMPRB amended Regulations to January 1, 2021. Official publication of the delay in Canada Gazette to follow (likely in CG2 on June ... Read More